Seattle Children's Research Institute will be one of Genezen's first customers to leverage its cutting-edge Cytegrity™ technology from biotech leader CSL for stable and scalable high-titer lentivirus ...

• Brazil emerges as one of the leaders in experience management The XLA Institute today announced the release of "State of XLA 2025," the first comprehensive, global industry report examining the ...

XLA is characterized by hypogammaglobulinemia and absent B cells, but normal numbers of pre-B cells. Atypical cases of XLA have been reported in which immunoglobulin concentrations are higher than ...

XLA patients have a defect of B cell maturation involving the pre B to B cell stages. This block is not absolute since circulating immunoglobulin (Ig) B cells may be found in XLA. To evaluate B cell ...